These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 21560084

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. alpha-Synucleinopathy in the human olfactory system in Parkinson's disease: involvement of calcium-binding protein- and substance P-positive cells.
    Ubeda-Bañon I, Saiz-Sanchez D, de la Rosa-Prieto C, Argandoña-Palacios L, Garcia-Muñozguren S, Martinez-Marcos A.
    Acta Neuropathol; 2010 Jun; 119(6):723-35. PubMed ID: 20383714
    [Abstract] [Full Text] [Related]

  • 23. The progression of pathology in Parkinson's disease.
    Halliday GM, McCann H.
    Ann N Y Acad Sci; 2010 Jan; 1184():188-95. PubMed ID: 20146698
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
    Yamada M, Iwatsubo T, Mizuno Y, Mochizuki H.
    J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Neuropathology of dementia in Parkinson's disease: a prospective, community-based study.
    Aarsland D, Perry R, Brown A, Larsen JP, Ballard C.
    Ann Neurol; 2005 Nov; 58(5):773-6. PubMed ID: 16240351
    [Abstract] [Full Text] [Related]

  • 29. [The mechanism of Lewy body formation in Parkinson's disease].
    Wakabayashi K, Takahashi H.
    Nihon Rinsho; 2000 Oct; 58(10):2022-7. PubMed ID: 11068441
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Biomarkers: Parkinson disease with dementia and dementia with Lewy bodies.
    Johansen KK, White LR, Sando SB, Aasly JO.
    Parkinsonism Relat Disord; 2010 Jun; 16(5):307-15. PubMed ID: 20338799
    [Abstract] [Full Text] [Related]

  • 34. Dementia in Parkinson's disease challenges the "gold standard".
    Levy G.
    Ann Neurol; 2005 Nov; 58(5):663-5. PubMed ID: 16240335
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. A stable proportion of Lewy body bearing neurons in the substantia nigra suggests a model in which the Lewy body causes neuronal death.
    Greffard S, Verny M, Bonnet AM, Seilhean D, Hauw JJ, Duyckaerts C.
    Neurobiol Aging; 2010 Jan; 31(1):99-103. PubMed ID: 18457903
    [Abstract] [Full Text] [Related]

  • 37. Immunohistochemical localization of X-linked inhibitor of apoptosis protein in brainstem-type and cortical Lewy bodies.
    Kawamoto Y, Ito H, Ihara M, Takahashi R.
    Neuroreport; 2012 Feb 15; 23(3):162-7. PubMed ID: 22273571
    [Abstract] [Full Text] [Related]

  • 38. α-Synuclein and Lewy pathology in Parkinson's disease.
    Kalia LV, Kalia SK.
    Curr Opin Neurol; 2015 Aug 15; 28(4):375-81. PubMed ID: 26110807
    [Abstract] [Full Text] [Related]

  • 39. Neuropathologic analysis of Lewy-related α-synucleinopathy in olfactory mucosa.
    Funabe S, Takao M, Saito Y, Hatsuta H, Sugiyama M, Ito S, Kanemaru K, Sawabe M, Arai T, Mochizuki H, Hattori N, Murayama S.
    Neuropathology; 2013 Feb 15; 33(1):47-58. PubMed ID: 22672612
    [Abstract] [Full Text] [Related]

  • 40. Methamphetamine binds to α-synuclein and causes a conformational change which can be detected by nanopore analysis.
    Tavassoly O, Lee JS.
    FEBS Lett; 2012 Sep 21; 586(19):3222-8. PubMed ID: 22771474
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.